back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-01-29 13:32 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+31,893 vol |
36,286 | |
| Filed 2025-01-29 12:47 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+31,893 vol |
36,286 | |
| Filed 2025-01-29 12:47 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+31,893 vol |
||
| Filed 2025-01-29 12:46 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-58,430 vol |
29,817 | |
| Filed 2024-12-20 17:23 Tx date 2024-12-18 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+74,180 vol |
88,247 | |
| Filed 2024-12-20 17:22 Tx date 2024-12-18 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$66,444
+58,800 vol $1.13 each |
237,200 | |
| Filed 2024-12-12 10:06 Tx date 2024-12-09 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,164 vol |
4,393 | |
| Filed 2024-12-12 10:06 Tx date 2024-12-09 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,067 vol |
14,067 | |
| Filed 2024-12-12 10:04 Tx date 2024-12-11 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-30,000 vol |
178,400 | |
| Filed 2024-11-28 10:25 Tx date 2024-11-27 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,229 vol |
1,229 | |
| Filed 2024-11-28 10:24 Tx date 2023-02-24 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-28 10:23 Tx date 2024-11-27 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,966 vol |
19,134 | |
| Filed 2023-12-13 15:05 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+15,200 vol |
21,100 | |
| Filed 2023-12-13 15:05 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$108,297
+56,700 vol $1.91 each |
208,400 | |
| Filed 2023-08-18 11:54 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,900 vol |
5,900 | |
| Filed 2023-08-18 11:53 Tx date 2023-02-24 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-18 11:53 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,891
+21,700 vol $2.76 each |
151,700 | |
| Filed 2023-02-24 12:45 Tx date 2023-02-24 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
130,000 |